NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET 2019-2027


MARKET OUTLOOK
Triton Market Research's report on the injectable drug delivery market in North America estimates the market to grow at a CAGR of 7.61% in the forecast period.
The United States and Canada together constitute the North American injectable drug delivery market.
Since the countries in North America are technologically advanced with better quality healthcare infrastructure, high revenue is generated from the region as compared to others. North America ranks second in the revenue generation in the injectable drug delivery system market, with the US being the highest contributor.
The increase in the number of cancer patients, coupled with the demand for better and effective treatment, is the main factor in boosting the demand for injectable drug delivery technology in Canada over the forecasted period. Rising cases of chronic diseases such as diabetes and arthritis are anticipated to encourage self-administration of drugs, thereby increasing the demand for injectable drug delivery systems. The introduction of nanoparticle-based drug delivery systems has gained huge popularity and encouragement in cancer treatments. Nano-particles, a component of nano-medicines, is considered as one of the promising drug delivery systems for cancer treatment. The increase in the adaptability of the biologics and its development will instigate the market growth of the injectable drug delivery systems. 
Various research and developments on the injectable drug delivery technology have been conducted in Canada following the ongoing biologics sector advancement. For example, the University of Toronto Lab has created orally absorbable molecules, derived from peptides that can be used in the cases of irritable bowels. 
COMPETITIVE OUTLOOK
Few of the eminent companies in the injectable drug delivery market are Teva Pharmaceutical Industries Ltd, West Pharmaceutical Services Inc, Novartis AG, Novo Nordis A/S, GERRESHEIMER, INJEX and SCHOTT AG.
TABLE OF CONTENT 
1. NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. MARKET DEFINITIONS
2.2. PORTER'S FIVE FORCES MODEL
2.2.1. THREAT OF NEW ENTRANT
2.2.2. THREAT OF SUBSTITUTE
2.2.3. BARGAINING POWER OF BUYERS
2.2.4. BARGAINING POWER OF SUPPLIERS
2.2.5. INTENSITY OF COMPETITIVE RIVALRY
2.3. MARKET SHARE OUTLOOK
2.4. KEY INSIGHT
2.5. KEY BUYING CRITERIA
2.6. LEGAL REQUIREMENT
2.7. REGULATORY FRAMEWORK
2.8. MARKET ATTRACTIVENESS INDEX
2.9. MARKET DRIVERS
2.9.1. INCREASING GERIATRIC POPULATION
2.9.2. TECHNOLOGICAL ADVANCEMENT
2.9.3. GROWING OCCURRENCE OF AUTOIMMUNE DISEASES
2.10.  MARKET RESTRAINT
2.10.1. HIGH MANUFACTURING COST OF THE INJECTABLE DRUG DELIVERY
2.11. MARKET OPPORTUNITY
2.11.1. DEVELOPMENT OF BETTER INJECTABLE SYSTEMS
2.12. MARKET CHALLENGES
2.12.1. DEVELOPMENTS IN THE ALTERNATE DRUG DELIVERY SYSTEM
2.12.2. STRINGENT REGULATIONS
3. INJECTABLE DRUG DELIVERY MARKET OUTLOOK - BY DEVICE TYPE
3.1. PEN INJECTOR
3.2. AUTO?INJECTOR
3.3. NEEDLE-FREE INJECTOR
3.4. PREFILLED SYRINGE
4. INJECTABLE DRUG DELIVERY MARKET OUTLOOK - BY ROUTE OF ADMINISTRATION
4.1. SUBCUTANEOUS
4.2. INTRAMUSCULAR
4.3. INTRAVENOUS (IV)
4.4. OTHER ROUTE OF ADMINISTRATION
5. INJECTABLE DRUG DELIVERY MARKET OUTLOOK - BY END-USER
5.1. CLINICS/ PHYSICIAN OFFICES
5.2. AMBULATORY CARE
5.3. HOSPITAL
5.4. HOME BASED
5.5. OTHERS END-USER
6. INJECTABLE DRUG DELIVERY MARKET – NORTH AMERICA
6.1. COUNTRY ANALYSIS
6.1.1. THE UNITED STATES
6.1.2. CANADA
7. COMPANY PROFILES
7.1. BAXTER 
7.2. BECTON, DICKINSON AND COMPANY (BD)
7.3. ELCAM MEDICAL
7.4. ELI LILLY AND COMPANY
7.5. GERRESHEIMER 
7.6. INJEX 
7.7. NOVARTIS AG
7.8. NOVO NORDISK A/S
7.9. PFIZER INC
7.10. SANOFI
7.11. SCHOTT AG
7.12. TERUMO CORPORATION
7.13. TEVA PHARMACEUTICAL INDUSTRIES LTD
7.14. WEST PHARMACEUTICAL SERVICES INC
7.15. YPSOMED
8. RESEARCH METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE & DELIVERABLES
8.1.1. OBJECTIVES OF STUDY
8.1.2. SCOPE OF STUDY
8.2. SOURCES OF DATA
8.2.1. PRIMARY DATA SOURCES
8.2.2. SECONDARY DATA SOURCES
8.3. RESEARCH METHODOLOGY
8.3.1. EVALUATION OF PROPOSED MARKET
8.3.2. IDENTIFICATION OF DATA SOURCES
8.3.3. ASSESSMENT OF MARKET DETERMINANTS
8.3.4. DATA COLLECTION
8.3.5. DATA VALIDATION & ANALYSIS
 
 
LIST OF TABLES 
TABLE 1  NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) 
TABLE 2 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY DEVICE TYPE, 2019-2027 ($ MILLION) 
TABLE 3 DIFFERENT TYPES OF INSULIN PEN INJECTORS 
TABLE 4 MARKETED NEEDLE-FREE INJECTORS PRODUCTS 
TABLE 5 LYOPHILIZED DRUGS USED IN PREFILLED SYRINGE
TABLE 6 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2019-2027 ($ MILLION) 
TABLE 7 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY END-USER, 2019-2027 ($ MILLION) 
TABLE 8 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY COUNTRY, 2019-2027 ($ MILLION)  
LIST OF FIGURES 
FIGURE 1 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) 
FIGURE 2 COMPANY MARKET SHARE OUTLOOK 2017 (%) 
FIGURE 3 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY PEN INJECTOR, 2019-2027 ($ MILLION) 
FIGURE 4 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY AUTO?INJECTOR, 2019-2027 ($ MILLION) 
FIGURE 5 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY NEEDLE-FREE INJECTOR, 2019-2027 ($ MILLION) 
FIGURE 6 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY PREFILLED, 2019-2027 ($ MILLION) 
FIGURE 7 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY SUBCUTANEOUS, 2019-2027 ($ MILLION) 
FIGURE 8 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY INTRAMUSCULAR, 2019-2027 ($ MILLION) 
FIGURE 9 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY INTRAVENOUS, 2019-2027 ($ MILLION) 
FIGURE 10 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY OTHER ROUTE OF ADMINISTRATION, 2019-2027 ($ MILLION) 
FIGURE 11 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY CLINICS/ PHYSICIAN OFFICES, 2019-2027 ($ MILLION) 
FIGURE 12 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY AMBULATORY CARE, 2019-2027 ($ MILLION) 
FIGURE 13 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY HOSPITAL, 2019-2027 ($ MILLION) 
FIGURE 14 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY HOME BASED, 2019-2027 ($ MILLION) 
FIGURE 15 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY OTHER END-USER, 2019-2027 ($ MILLION) 
FIGURE 16 THE UNITED STATES INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) 
FIGURE 17 CANADA INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION)

LIST OF TABLES TABLE 1 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) TABLE 2 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY DEVICE TYPE, 2019-2027 ($ MILLION) TABLE 3 DIFFERENT TYPES OF INSULIN PEN INJECTORS TABLE 4 MARKETED NEEDLE-FREE INJECTORS PRODUCTS TABLE 5 LYOPHILIZED DRUGS USED IN PREFILLED SYRINGE TABLE 6 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2019-2027 ($ MILLION) TABLE 7 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY END-USER, 2019-2027 ($ MILLION) TABLE 8 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY COUNTRY, 2019-2027 ($ MILLION) LIST OF FIGURES FIGURE 1 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) FIGURE 2 COMPANY MARKET SHARE OUTLOOK 2017 (%) FIGURE 3 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY PEN INJECTOR, 2019-2027 ($ MILLION) FIGURE 4 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY AUTO?INJECTOR, 2019-2027 ($ MILLION) FIGURE 5 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY NEEDLE-FREE INJECTOR, 2019-2027 ($ MILLION) FIGURE 6 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY PREFILLED, 2019-2027 ($ MILLION) FIGURE 7 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY SUBCUTANEOUS, 2019-2027 ($ MILLION) FIGURE 8 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY INTRAMUSCULAR, 2019-2027 ($ MILLION) FIGURE 9 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY INTRAVENOUS, 2019-2027 ($ MILLION) FIGURE 10 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY OTHER ROUTE OF ADMINISTRATION, 2019-2027 ($ MILLION) FIGURE 11 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY CLINICS/ PHYSICIAN OFFICES, 2019-2027 ($ MILLION) FIGURE 12 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY AMBULATORY CARE, 2019-2027 ($ MILLION) FIGURE 13 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY HOSPITAL, 2019-2027 ($ MILLION) FIGURE 14 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY HOME BASED, 2019-2027 ($ MILLION) FIGURE 15 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY OTHER END-USER, 2019-2027 ($ MILLION) FIGURE 16 THE UNITED STATES INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) FIGURE 17 CANADA INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION)

Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:

New Pharmaceuticals and Healthcare Reports

Internal Neuromodulation Market Forecast 2025 | Global Report

Rising number of patients suffering from neurological disorders such as Parkinson’s, essential tremor, and primary dystonia is fueling the demand for internal neuromodulation procedures. Chronic back and leg pain associated with PVD (peripheral...

Gastrointestinal Cancer Treatment Market Size 2020-2025 | Growth Forecasts

As per credible projections, gastrointestinal cancer treatment industry is expected to register strong CAGR over 2019-2025. Rising adoption of unhealthy eating habits and increasing consumption of tobacco and alcohol have increased the pervasiveness ...

Topotecan Hydrochloride Market Trends and Research Insights by 2025

As per credible estimates, global topotecan hydrochloride market is poised to acquire commendable gains by the year 2025. Rising adoption of unhealthy and sedentary lifestyle has increased the pervasiveness of small cell lung cancer, ovarian cancer, ...

Flu Vaccine Market Share 2020-2025 | Global Industry Report

As per trusted estimates, global flu vaccine market will record substantial growth during 2020-2025. Increasing government initiatives to ensure the safety of the populace, minimal side-effects associated with influenza vaccines, improving efficacy o...

Healthcare Linen Market Size - Industry Trends Report 2025

According to reliable projections, global healthcare linen market is projected to record considerable growth during 2020-2025. Rising prevalence of various diseases including cardiovascular diseases, cancer, and arthritis along with increasing cases ...

Other Reports by Triton Market Research

GLOBAL RECYCLED GLASS MARKET 2020-2028

MARKET OUTLOOK According to Triton, the global recycled glass market is expected to display a positive market trend over the forecast years 2020-2028, exhibiting a CAGR of 6.02% (by revenue) and 6.25% (by volume). Glass has several advantageous prope...

GLOBAL PP NONWOVEN MARKET 2020-2028

MARKET OUTLOOK As per an analysis by the Triton Market Research on the global PP nonwoven market, it is estimated that the industry would show growth at a CAGR of 7.05% in the period 2020-2028. PP nonwoven material is used in the production of diaper...

NORTH AMERICA PP NONWOVEN MARKET 2020-2028

MARKET OUTLOOK A Triton Market Research report on the North American PP nonwoven market depicts that the market is likely to show growth at a CAGR of 6.87% in the forecast period between 2020 and 2028. The United States and Canada comprises the North...

MIDDLE EAST AND AFRICA PP NONWOVEN MARKET 2020-2028

MARKET OUTLOOK As per a Triton Market Research report, the PP nonwoven market in the Middle East and Africa is set to accelerate at a CAGR of 8.51% during the forecast period 2020-2028. Saudi Arabia, Turkey, the United Arab Emirates and the Rest of t...

LATIN AMERICA PP NONWOVEN MARKET 2020-2028

MARKET OUTLOOK A Triton Market Research report illustrates that the Latin American PP nonwoven market would exhibit a CAGR of 7.28% during the estimated period 2020-2028. Brazil, Mexico and the Rest of Latin America together form the PP nonwoven mark...

Publisher: Triton Market Research